EarlySense, a Ramat Gan, Israel- and and Woburn, Massachusetts-based provider of contact-free continuous monitoring solutions across the care continuum, completed a $39m financing round.
The majority of the funding came from Hill-Rom (NYSE: HRC), a global provider of medical technologies and a leading hospital bed manufacturer, and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company (NYSE: WFC). Other new investors include BlueRed Capital, Israel Innovation Fund, Argos Capital and Hotung Capital. Existing investors included Pitango Venture Capital and JK&B Venture Capital.
Led by Avner Halperin, CEO, EarlySense provides contact-free, continuous monitoring solutions for the healthcare continuum. Used worldwide in hospitals, post-acute care facilities, and homes, EarlySense assists clinicians in early detection of patient deterioration. The solution has been proven to help prevent adverse events, including code blue events which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers, and hospital readmissions. Its FDA-cleared solutions leverage Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes.
Hill-Rom’s investment follows the hospital bed manufacturer’s launch of the Centrella® Smart+ Bed, a hospital bed with integrated continuous contact-free heart rate and respiratory rate sensing and analytics technology.
EarlySense’s FDA-cleared and CE-approved solutions are used by healthcare facilities around the world.